At a glance
- Originator Nonindustrial source
- Class Antihyperglycaemics; Naphthoquinones
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 29 Aug 1996 No-Development-Reported for Diabetes mellitus in Japan (Unknown route)
- 29 Aug 1996 No-Development-Reported for Diabetes mellitus in USA (Unknown route)
- 14 Oct 1994 Preclinical development for Diabetes mellitus in Japan (Unknown route)